or
Remember me
Back
Revolutionizing Malaria Treatment: The Role of AI and Adnexus Biotech
Malaria remains one of the deadliest diseases worldwide, claiming over 600,000 lives annually, with the majority of cases concentrated in Sub-Saharan Africa and Southeast Asia. This mosquito-borne disease, caused by Plasmodium parasites, presents a significant global health challenge. While strides have been made in treatment and prevention, the emergence of drug-resistant strains necessitates innovative solutions. Adnexus Biotechnologies Inc. is at the forefront of this battle, leveraging its AI-powered Sutra™ platform to develop groundbreaking treatments like Trapicolast.
Receive investor kits and email updates from Stockhouse and directly from these companies.